Effect of Semaglutide and Empagliflozin on Pulmonary Structure and Proteomics in Obese Mice

Overview

Journal Diabetes Metab Syndr Obes

Publisher Dove Medical Press

Specialty Endocrinology

Date 2024 Mar 18

PMID 38496002

Authors

Yu Yang

Xiaoyu Pan

Shuchun Chen

Affiliations

Soon will be listed here.

Abstract

Objective: This study utilized proteomics to investigate changes in protein expression associated with lung health in obese mice exposed to semaglutide and empagliflozin through a high-fat diet.

Methods: Twenty-eight male C57BL/6JC mice were randomly assigned to two groups: a control diet group (n = 7) and a high-fat diet group (n = 21). The HFD group was further divided into three groups: HFD group (n = 7), Sema group (n = 7), and Empa group (n = 7). Post-treatment, mice underwent assessments including glucose tolerance, lipids, oxidative stress markers, body weight, lung weight, and structure. Proteomics identified differentially expressed proteins (DEPs) in lung tissue, and bioinformatics analyzed the biological processes and functions of these proteins.

Results: Semaglutide and empagliflozin significantly attenuated obesity-induced hyperglycemia, abnormal lipid metabolism, oxidative stress response, and can decrease alveolar wall thickness, enlarge alveolar lumen, and reduce collagen content in lung tissue. Both medications also attenuated lung elastic fibre cracking and disintegration. In the HFD/NCD group, there were 66 DEPs, comprising 30 proteins that were increased and 36 that were decreased. Twenty-three DEPs overlapped between Sema/HFD and Empa/HFD, with 11 up-regulated and 12 down-regulated simultaneously. After analysing DEPs in different groups, four proteins - LYVE1, BRAF, RGCC, and CHMP5 - were all downregulated in the HFD group and upregulated by semaglutide and empagliflozin treatment.

Conclusion: This study demonstrates that obesity induced by a high-fat diet causes a reduction in the expression of LYVE1, BRAF, RGCC, and CHMP5 proteins, potentially affecting lung function and structure in mice. Significantly, the administration of semaglutide and empagliflozin elevates the levels of these proteins, potentially offering therapeutic benefits against lung injury caused by obesity. Merging semaglutide with empagliflozin may exert a more pronounced impact.

References

Alexander J, Chaitanya G, Grisham M, Boktor M . Emerging roles of lymphatics in inflammatory bowel disease. Ann N Y Acad Sci. 2010; 1207 Suppl 1:E75-85. DOI: 10.1111/j.1749-6632.2010.05757.x. View

Jaochico A, Sangaraju D, Shahidi-Latham S . A rapid derivatization based LC-MS/MS method for quantitation of short chain fatty acids in human plasma and urine. Bioanalysis. 2019; 11(8):741-753. DOI: 10.4155/bio-2018-0241. View

Cui Y, Liu K, Lamattina A, Visner G, El-Chemaly S . Lymphatic Vessels: The Next Frontier in Lung Transplant. Ann Am Thorac Soc. 2017; 14(Supplement_3):S226-S232. PMC: 5711339. DOI: 10.1513/AnnalsATS.201606-465MG. View

Jiang Z, Tan J, Yuan Y, Shen J, Chen Y . Semaglutide ameliorates lipopolysaccharide-induced acute lung injury through inhibiting HDAC5-mediated activation of NF-κB signaling pathway. Hum Exp Toxicol. 2022; 41:9603271221125931. DOI: 10.1177/09603271221125931. View

Klonoff D, Bassock S, Engels E, Frederiksen M, Marber M, Qvist M . Semaglutide single-dose pen-injector: Post hoc analysis of summative usability testing for weight management. Diabetes Obes Metab. 2021; 23(11):2590-2594. PMC: 9292194. DOI: 10.1111/dom.14509. View

Plubell D, Wilmarth P, Zhao Y, Fenton A, Minnier J, Reddy A . Extended Multiplexing of Tandem Mass Tags (TMT) Labeling Reveals Age and High Fat Diet Specific Proteome Changes in Mouse Epididymal Adipose Tissue. Mol Cell Proteomics. 2017; 16(5):873-890. PMC: 5417827. DOI: 10.1074/mcp.M116.065524. View

OConnell J, Paulo J, OBrien J, Gygi S . Proteome-Wide Evaluation of Two Common Protein Quantification Methods. J Proteome Res. 2018; 17(5):1934-1942. PMC: 5984592. DOI: 10.1021/acs.jproteome.8b00016. View

Niu S, Ren Q, Chen S, Pan X, Yue L, Chen X . Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice. Diabetes Metab Syndr Obes. 2023; 16:2549-2560. PMC: 10461752. DOI: 10.2147/DMSO.S422327. View

Hanash S . Disease proteomics. Nature. 2003; 422(6928):226-32. DOI: 10.1038/nature01514. View

10.

Alitalo K . The lymphatic vasculature in disease. Nat Med. 2011; 17(11):1371-80. DOI: 10.1038/nm.2545. View

11.

Gregg E, Shaw J . Global Health Effects of Overweight and Obesity. N Engl J Med. 2017; 377(1):80-81. DOI: 10.1056/NEJMe1706095. View

12.

Ge X, Greenberg Y, Hosseinkhani M, Long E, Bahaie N, Rao A . High-fat diet promotes lung fibrosis and attenuates airway eosinophilia after exposure to cockroach allergen in mice. Exp Lung Res. 2013; 39(9):365-78. PMC: 4474470. DOI: 10.3109/01902148.2013.829537. View

13.

Akishima Y, Ito K, Zhang L, Ishikawa Y, Orikasa H, Kiguchi H . Immunohistochemical detection of human small lymphatic vessels under normal and pathological conditions using the LYVE-1 antibody. Virchows Arch. 2004; 444(2):153-7. DOI: 10.1007/s00428-003-0950-8. View

14.

Wang L, Chen Q, Liu T, Bai T, Zhang M, Hu Y . Role and mechanism of benzo[a]pyrene in the transformation of chronic obstructive pulmonary disease into lung adenocarcinoma. J Cancer Res Clin Oncol. 2022; 149(8):4741-4760. DOI: 10.1007/s00432-022-04353-y. View

15.

Guo H, Jian Z, Liu H, Cui H, Deng H, Fang J . TGF-β1-induced EMT activation via both Smad-dependent and MAPK signaling pathways in Cu-induced pulmonary fibrosis. Toxicol Appl Pharmacol. 2021; 418:115500. DOI: 10.1016/j.taap.2021.115500. View

16.

Boucherat O, Landry-Truchon K, Aoidi R, Houde N, Nadeau V, Charron J . Lung development requires an active ERK/MAPK pathway in the lung mesenchyme. Dev Dyn. 2016; 246(1):72-82. DOI: 10.1002/dvdy.24464. View

17.

Wanner C, Inzucchi S, Lachin J, Fitchett D, von Eynatten M, Mattheus M . Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes. N Engl J Med. 2016; 375(4):323-34. DOI: 10.1056/NEJMoa1515920. View

18.

Sharp J, Henry J, SWEANY S, MEADOWS W, Pietras R . THE TOTAL WORK OF BREATHING IN NORMAL AND OBESE MEN. J Clin Invest. 1964; 43:728-39. PMC: 289549. DOI: 10.1172/JCI104957. View

19.

Benito E, Blazquez E, Bosch M . Glucagon-like peptide-1-(7-36)amide increases pulmonary surfactant secretion through a cyclic adenosine 3',5'-monophosphate-dependent protein kinase mechanism in rat type II pneumocytes. Endocrinology. 1998; 139(5):2363-8. DOI: 10.1210/endo.139.5.5998. View

20.

Johnson L, Prevo R, Clasper S, Jackson D . Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1. J Biol Chem. 2007; 282(46):33671-33680. DOI: 10.1074/jbc.M702889200. View